Analysis on Pharmacy Trusteeship in Nanjing and Influence on Pharmaceutical Manufacturers
| Publication Date | May 2008 |
|---|---|
| Publisher | Sunfaith China |
| Product Type | Article |
| Pages | 8 |
| ISBN Number | not applicable |
| Product Code | SFC00067 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Pharmacy Trusteeship refers to that public hospitals outsource the Pharmacy business to outside pharmacy companies, which adopt non-free management model. The mode is greatly popularized in Nanjing, Jiangsu.
As Pharmacy trusteeship only changes the operation right, and no increase for the government investment, the proportion of hospitals' drug sales income is still very large, and the "Gray channel" of prescription and drug sales also exist.
To branded drug manufacturers, due to the increasing cost and pursuit for profit, the trusteeship companies are forced to introduce generic drugs instead of low-profit name brand drugs. Therefore, brand drug manufacturers should adjust their marketing mode in multi-aspects to deal with the problem.
Content
- 1. Introduction of Pharmacy Trusteeship Mode
- 2. Advantages and Disadvantages of Pharmacy Trusteeship
- 2.1 Advantages of Pharmacy Trusteeship
- 2.2 Disadvantages of Pharmacy Trusteeship
- Chart 1: Income Segmentation of Chinese Hospitals in 2006
- Chart 2: Control Index of drug sales income rate for Jiangsu Third-tier Hospitals in 2004
- 3. Influence on Drug Manufacturers
- 4. Possible Solutions from Branded Drug Manufacturers
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
Product features / use
| Scope | Concise Overview | ![]() |
| Level | General Industry Strategies | ![]() |
| Data | Headline Market Data | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories












